These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7909232)

  • 21. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
    Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection.
    Schønning K; Joost M; Gram GJ; Machuca R; Nielsen C; Nielsen JO; Hansen JE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):195-202. PubMed ID: 9665495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV-1-infected individuals.
    Bieniasz PD; Ariyoshi K; Bourelly MA; Bloor S; Foxall RB; Harwood EC; Weber JN
    AIDS; 1993 Jun; 7(6):803-6. PubMed ID: 8103340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and plasma viral load in patients infected with HIV-2.
    Simon F; Matheron S; Tamalet C; Loussert-Ajaka I; Bartczak S; Pépin JM; Dhiver C; Gamba E; Elbim C; Gastaut JA
    AIDS; 1993 Nov; 7(11):1411-7. PubMed ID: 7904166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O.
    Nkengasong JN; Fransen K; Willems B; Karita E; Vingerhoets J; Kestens L; Colebunders R; Piot P; van der Groen G
    J Med Virol; 1997 Mar; 51(3):202-9. PubMed ID: 9139084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection.
    Greenough TC; Somasundaran M; Brettler DB; Hesselton RM; Alimenti A; Kirchhoff F; Panicali D; Sullivan JL
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):395-403. PubMed ID: 8068417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual Immunity Concomitantly Suppresses HIV-1 Progression.
    Qureshi H; Bhattacharya J
    Trends Microbiol; 2017 May; 25(5):334-335. PubMed ID: 28284876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
    Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
    AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma.
    Andreoni M; Sarmati L; Parisi SG; Ercoli L; Rocchi G
    J Med Virol; 1992 Nov; 38(3):207-13. PubMed ID: 1363119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease.
    Gómez AM; Smaill FM; Rosenthal KL
    Clin Exp Immunol; 1994 Jul; 97(1):68-75. PubMed ID: 7518369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
    Pilgrim AK; Pantaleo G; Cohen OJ; Fink LM; Zhou JY; Zhou JT; Bolognesi DP; Fauci AS; Montefiori DC
    J Infect Dis; 1997 Oct; 176(4):924-32. PubMed ID: 9333150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy.
    Lu W; Salerno-Goncalves R; Yuan J; Sylvie D; Han DS; Andrieu JM
    AIDS; 1995 Jan; 9(1):35-42. PubMed ID: 7893439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
    Bunnik EM; Lobbrecht MS; van Nuenen AC; Schuitemaker H
    Virology; 2010 Feb; 397(1):224-30. PubMed ID: 19945135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
    Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
    Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.
    Bunnik EM; van Gils MJ; Lobbrecht MS; Pisas L; Nanlohy NM; van Baarle D; van Nuenen AC; Hessell AJ; Schuitemaker H
    J Gen Virol; 2010 May; 91(Pt 5):1354-64. PubMed ID: 20053822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lymphoid organs in the pathogenesis of HIV infection.
    Pantaleo G; Graziosi C; Fauci AS
    Semin Immunol; 1993 Jun; 5(3):157-63. PubMed ID: 8102261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS.
    Scarlatti G; Leitner T; Hodara V; Jansson M; Karlsson A; Wahlberg J; Rossi P; Uhlén M; Fenyö EM; Albert J
    Immunol Lett; 1996 Jun; 51(1-2):23-8. PubMed ID: 8811340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina.
    McClure J; Schmidt AM; Rey-Cuille MA; Bannink J; Misher L; Tsai CC; Anderson DM; Morton WR; Hu SL
    J Med Primatol; 2000 Aug; 29(3-4):114-26. PubMed ID: 11085573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.
    Seth N; Kaufmann D; Lahey T; Rosenberg ES; Wucherpfennig KW
    J Immunol; 2005 Nov; 175(10):6948-58. PubMed ID: 16272355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.